PSMA PET/CT Patterns of Recurrence After Mono-Brachytherapy in Men with Low and Intermediate Prostate Cancer and Subsequent Management
Bibliographic record
Abstract
Abstract Purpose Brachytherapy as monotherapy is a recommended treatment option for men with low to intermediate risk prostate cancer, achieving biochemical progression-free survival rates >95% at 5 years. Local recurrence is difficult to identify due to sensitivity of conventional imaging and post-brachytherapy artefacts. Biochemical recurrence (BCR) in this setting is often considered as systemic recurrence, treated with androgen-deprivation therapy (ADT) as primary salvage therapy. This study investigated PSMA PET/CT for recurrence after low-dose rate (LDR) and high-dose rate (HDR) brachytherapy as monotherapy in men with low or intermediate prostate cancer, as well as subsequent management when recurrence occurred only within the prostate. Methods We performed a retrospective single-centre analysis for patients who were treated with brachytherapy as monotherapy for prostate cancer from May 2002 to May 2021 to identify men who underwent [68Ga]Ga-PSMA-11 or [18F]DCFPyL PET/CT (PSMA PET/CT) for BCR. We report the findings on PSMA PET/CT, quantitative parameters, as well as the subsequent management of the patients. Results Forty patients were identified who underwent PSMA PET/CT (26 LDR and 14 HDR) to investigate a rising PSA at a median (IQR) of 7 years (3.0-10.8) after initial therapy. Median (IQR) PSA at time of PSMA PET/CT was 6.6 ng/mL (3.9 - 15.5). On PSMA PET/CT, 20/40 (50%) men had prostate-only recurrence, 5/40 (12.5%) had nodal recurrence, 2/40 (5%) had bone-only metastases, 10/40 (25%) had multiple sites of recurrence and 3/40 (7.5%) had no visible sites of recurrence. Of the 20 patients with prostate-only recurrence, 8/20 (40%) had recurrence in a high-dose radiation zone, such as within the brachytherapy seeds, versus 7/20 (35%) in an under-covered zone, such as seminal vesicles or prostate base. On PSMA PET/CT, recurrence within the prostate had median (IQR) SUVmax 10.4 (5.1-15.7) and volume 2.9 mL (2.0-11.2). Subsequent management of these patients with local recurrence included surveillance followed by ADT (9/20, 45%), salvage SBRT (3/20, 15%), salvage brachytherapy (2/20, 10%), salvage radical prostatectomy (1/20, 5%) and not treated/lost to follow-up (5/20, 25%). For those with surveillance followed by ADT, the mean time before introduction of ADT was 4.1 years (range 1 to 8 years). Conclusion In the setting of BCR following mono-brachytherapy, PSMA PET/CT effectively identified local recurrence occurring within the prostate, including within high-dose radiation zones. It may be safe to delay the introduction of ADT, though more research is required.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".